摘要
目的对冠心病并发快速心律失常的急诊治疗中,应用胺碘酮的临床效果以及安全性进行观察和探讨。方法选取我院2011年1月~2014年1月收治的冠心病快速心律失常患者90例,随机分为两组,各45例。对于两组都先采用常规治疗,对照组再应用普罗帕酮开展治疗,治疗组采用胺碘酮治疗,对比两组的治疗效果。结果两组患者相应的症状与体征都得到改善,治疗组总有效率高于对照组,差异具有统计学意义(P〈0.05)。结论胺碘酮治疗急诊冠心病并发快心律失常具有显著的临床效果,能够改善患者病情,可有效而安全的用于对患者的抢救。
Objective To observe and discuss the clinical efficacy and safety of amiodarone in emergency treatment of coronary heart disease complicated with rapid arrhythmia. Methods Selected 90 cases with coronary heart disease combined with tachyarrhythmia from January 2011 to January 2014 in our hospital, which were randomly divided into two groups, each group had 45 cases, two groups were first treated with conventional therapy, the control group used propafenone to carry out the treatment, the treatment group were treated with amiodarone therapy, compared two groups of treatment effect. Results The two groups of patients with symptoms and signs were improved, the results showed that the total effective rate of treatment group was higher than the control group, and the difference between the groups was statistically significant(P〈0.05). Conclusion Amiodarone in the treatment of emergency coronary heart disease complicated with fast arrhythmia has significant clinical effect, and can effectively improve the patient's condition, can be effective and safe for the rescue of these patients.
出处
《中国继续医学教育》
2016年第6期175-176,共2页
China Continuing Medical Education
关键词
胺碘酮
冠心病
快速心律失常
急诊
Amiodarone
Coronary heart disease
Tachyarrhythmia
Emergency